{"id":31176,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/","title":{"rendered":"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1471 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018<\/h2>\n<p>Les donn\u00e9es en vie r\u00e9elle constituent le meilleur moyen de comprendre comment identifier les patients qui r\u00e9pondent aux diff\u00e9rents m\u00e9dicaments et comment tirer parti de ces recherches. Dans cet \u00e9pisode, d\u00e9couvrez-en plus sur l\u2019efficacit\u00e9 et la r\u00e9ussite du traitement, ainsi que sur les donn\u00e9es cliniques relatives aux biom\u00e9dicaments. <\/p>\n<h3>Pan\u00e9listes<\/h3>\n<p>Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1472 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/0xkyGfRWcEc?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018 Les donn\u00e9es en vie r\u00e9elle constituent le meilleur moyen de comprendre comment identifier les patients qui r\u00e9pondent aux diff\u00e9rents m\u00e9dicaments et comment tirer parti de ces recherches. Dans cet \u00e9pisode, d\u00e9couvrez-en plus sur l\u2019efficacit\u00e9 et la r\u00e9ussite du traitement, ainsi que sur les donn\u00e9es cliniques relatives aux biom\u00e9dicaments. Pan\u00e9listes Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.<\/p>\n","protected":false},"author":1,"featured_media":31196,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[189],"tags":[170,172,174,175,190,191,192,194],"class_list":["post-31176","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-professionnels-de-sante","tag-asthme","tag-crswnp","tag-biotherapies","tag-rhinologie","tag-debats","tag-rhinology-future-debates","tag-rhinosinusite-chronique-rsc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme\" \/>\n<meta property=\"og:description\" content=\"Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018 Les donn\u00e9es en vie r\u00e9elle constituent le meilleur moyen de comprendre comment identifier les patients qui r\u00e9pondent aux diff\u00e9rents m\u00e9dicaments et comment tirer parti de ces recherches. Dans cet \u00e9pisode, d\u00e9couvrez-en plus sur l\u2019efficacit\u00e9 et la r\u00e9ussite du traitement, ainsi que sur les donn\u00e9es cliniques relatives aux biom\u00e9dicaments. Pan\u00e9listes Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/\",\"name\":\"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_17.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_17.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_17.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/","og_locale":"fr_FR","og_type":"article","og_title":"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme","og_description":"Rhinologie D\u00e9bats d&#8217;Avenir Bruxelles 2018 Les donn\u00e9es en vie r\u00e9elle constituent le meilleur moyen de comprendre comment identifier les patients qui r\u00e9pondent aux diff\u00e9rents m\u00e9dicaments et comment tirer parti de ces recherches. Dans cet \u00e9pisode, d\u00e9couvrez-en plus sur l\u2019efficacit\u00e9 et la r\u00e9ussite du traitement, ainsi que sur les donn\u00e9es cliniques relatives aux biom\u00e9dicaments. Pan\u00e9listes Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Repr\u00e9sentants des patients.","og_url":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"width":1280,"height":720,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/","url":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/","name":"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_17.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/donnees-cliniques-sur-les-biomedicaments-dans-la-crswnp-et-lasthme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"Donn\u00e9es cliniques sur les biom\u00e9dicaments dans la CRSwNP et l\u2019asthme"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/31176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=31176"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/31176\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/31196"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=31176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=31176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=31176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}